Biotech Breakthrough: Oryzon Genomics Captures Renewed Investor Enthusiasm
Oryzon Genomics' stock surged by 21% to 3.69 euros, marking a 140% increase this year, with market capitalization exceeding 230 million euros. The rise is driven by positive Phase IIa…